CH CRL (R4)
0.9.0 - Draft

This page is part of the CH CRL (R4) (v0.9.0: STU Draft) based on FHIR R4. . For a full list of available versions, see the Directory of published versions

Profiles

  • CH CRL Bundle

    Definition of the Bundle for reporting to the cancer registry

  • CH CRL Communication

    Definition of the Communication for the date of informing the patient about the cancer registration

  • CH CRL Composition

    Definition of the Composition for reporting to the cancer registry

  • CH CRL Condition Disease

    Definition of the Condition for diseases

  • CH CRL Condition Final Cause of Death

    Definition of the Condition for the final cause of death

  • CH CRL DocumentReference

    Definition of the DocumentReference for the report as PDF

  • CH CRL Encounter Treatment Decision

    Definition of the Encounter for the treatment decision

  • CH CRL Observation Ann Arbor Staging

    Definition of the Observation for the Ann Arbor staging

  • CH CRL Observation Associated In-situ Tumour

    Definition of the Observation for the associated in-situ tumour

  • CH CRL Observation Binet Staging

    Definition of the Observation for the Binet staging

  • CH CRL Observation Breslow Thickness

    Definition of the Observation for the Breslow thickness

  • CH CRL Observation COG ALL Staging

    Definition of the Observation for the COG ALL staging

  • CH CRL Observation COG Staging

    Definition of the Observation for the COG staging

  • CH CRL Observation Cerebrovascular Accident or Transient Ischemic Attack

    Definition of the Observation for the cerebrovascular accident or transient ischemic attack

  • CH CRL Observation Charlson Index

    Definition of the Observation for the Charlson index

  • CH CRL Observation Chronic Pulmonary Disease

    Definition of the Observation for the chronic pulmonary disease

  • CH CRL Observation Circumferential Resection Margins

    Definition of the Observation for the circumferential resection margins

  • CH CRL Observation Clinical Tumour Size

    Definition of the Observation for the clinical tumour size

  • CH CRL Observation Congestive Heart Failure

    Definition of the Observation for the congestive heart failure

  • CH CRL Observation Connective Tissue Disease - Rheumatic Disease

    Definition of the Observation for the connective tissue disease - rheumatic disease

  • CH CRL Observation Creasman Grading System

    Definition of the Observation for the Creasman grading system

  • CH CRL Observation DSSplus

    Definition of the Observation for the DSSplus

  • CH CRL Observation Date of Incidence

    Definition of the Observation for the date of incidence

  • CH CRL Observation Dementia

    Definition of the Observation for the dementia

  • CH CRL Observation Diabetes Mellitus

    Definition of the Observation for the diabetes mellitus

  • CH CRL Observation EBV

    Definition of the Observation for the EBV

  • CH CRL Observation Elston/Ellis Grading System

    Definition of the Observation for the Elston/Ellis grading system

  • CH CRL Observation FIGO Staging

    Definition of the Observation for the FIGO staging

  • CH CRL Observation Gleason Biopsy Most Common Grade

    Definition of the Observation for the Gleason biopsy most common grade

  • CH CRL Observation Gleason Biopsy Second Most Common or Highest Grade

    Definition of the Observation for the Gleason biopsy second most common or highest grade

  • CH CRL Observation Gleason Excision Most Common Grade

    Definition of the Observation for the Gleason excision most common grade

  • CH CRL Observation Gleason Excision Second Most Common or Highest Grade

    Definition of the Observation for the Gleason excision second most common or highest grade

  • CH CRL Observation Gleason Score

    Definition of the Observation for the Gleason score

  • CH CRL Observation HIV/AIDS

    Definition of the Observation for HIV/AIDS

  • CH CRL Observation HPV/p16

    Definition of the Observation for the HPV/p16

  • CH CRL Observation Hemiplegia / Paraplegia

    Definition of the Observation for the hemiplegia / paraplegia

  • CH CRL Observation Her2 Receptor Status

    Definition of the Observation for the Her2 receptor status

  • CH CRL Observation ICCC-3 Code

    Definition of the Observation for the ICCC-3 code

  • CH CRL Observation ICCC-3 Extended Code

    Definition of the Observation for the ICCC-3 extended code

  • CH CRL Observation ICCC-3 Main Group

    Definition of the Observation for the ICCC-3 main group

  • CH CRL Observation ICD-10

    Definition of the Observation for the ICD-10 code

  • CH CRL Observation ICD-O-3 Behaviour

    Definition of the Observation for the ICD-O-3 behaviour code

  • CH CRL Observation ICD-O-3 Histological Grade

    Definition of the Observation for the ICD-O-3 histological grade code

  • CH CRL Observation ICD-O-3 Laterality

    Definition of the Observation for the ICD-O-3 laterality code

  • CH CRL Observation ICD-O-3 Morphology

    Definition of the Observation for the ICD-O-3 morphology code

  • CH CRL Observation ICD-O-3 Morphology Post-transformation

    Definition of the Observation for the ICD-O-3 morphology term after transformation

  • CH CRL Observation ICD-O-3 Morphology Pre-transformation

    Definition of the Observation for the ICD-O-3 morphology term before change of main diagnosis

  • CH CRL Observation ICD-O-3 Topography

    Definition of the Observation for the ICD-O-3 topography code

  • CH CRL Observation INRGSS Staging

    Definition of the Observation for the INRGSS staging

  • CH CRL Observation IRSS Staging

    Definition of the Observation for the IRSS staging

  • CH CRL Observation ISS Staging

    Definition of the Observation for the ISS staging

  • CH CRL Observation LDH

    Definition of the Observation for the LDH

  • CH CRL Observation Liver Disease

    Definition of the Observation for the liver disease

  • CH CRL Observation Lugano Staging

    Definition of the Observation for the Lugano staging

  • CH CRL Observation Lymphatic Invasion

    Definition of the Observation for the lymphatic invasion

  • CH CRL Observation Metastases at Diagnosis Indicator

    Definition of the Observation for the metastases at diagnosis indicator

  • CH CRL Observation Microsatellite Instability

    Definition of the Observation for the microsatellite instability

  • CH CRL Observation Moderate to Severe Chronic Kidney Disease

    Definition of the Observation for the moderate to severe chronic kidney disease

  • CH CRL Observation Myocardial Infarction

    Definition of the Observation for the myocardial infarction

  • CH CRL Observation Number of Examined Regional Lymph Nodes

    Definition of the Observation for the number of examined regional lymph nodes

  • CH CRL Observation Number of Examined Sentinel Lymph Nodes

    Definition of the Observation for the number of examined sentinel lymph nodes

  • CH CRL Observation Number of Involved Regional Lymph Nodes

    Definition of the Observation for the number of involved regional lymph nodes

  • CH CRL Observation Number of Positive Sentinel Lymph Nodes

    Definition of the Observation for the number of positive sentinel lymph nodes

  • CH CRL Observation Oestrogen Receptor Status

    Definition of the Observation for the oestrogen receptor status

  • CH CRL Observation PRETEXT Staging

    Definition of the Observation for the PRETEXT staging

  • CH CRL Observation Pathological Tumour Size

    Definition of the Observation for the pathological tumour size

  • CH CRL Observation Peptic Ulcer Disease

    Definition of the Observation for the peptic ulcer disease

  • CH CRL Observation Perineural Invasion

    Definition of the Observation for the perineural invasion

  • CH CRL Observation Peripheral Vascular Disease

    Definition of the Observation for the peripheral vascular disease

  • CH CRL Observation Pretreatment Prostate Specific Antigen

    Definition of the Observation for the pretreatment prostate specific antigen (PSA)

  • CH CRL Observation Progesterone Receptor Status

    Definition of the Observation for the progesterone receptor status

  • CH CRL Observation Rai Staging

    Definition of the Observation for the Rai staging

  • CH CRL Observation Resection Margin In-situ Tumour

    Definition of the Observation for the resection margin in-situ tumour

  • CH CRL Observation Resection Margin Invasive Tumour

    Definition of the Observation for the resection margin invasive tumour

  • CH CRL Observation Residual In-situ Tumour

    Definition of the Observation for the residual in-situ tumour

  • CH CRL Observation Residual Invasive Tumour

    Definition of the Observation for the residual invasive tumour

  • CH CRL Observation Rhabdomyosarcoma Site Staging

    Definition of the Observation for the Rhabdomyosarcoma site staging

  • CH CRL Observation SIOP Staging

    Definition of the Observation for the SIOP staging

  • CH CRL Observation SalzerKuntschik Grading System

    Definition of the Observation for the SalzerKuntschik grading system

  • CH CRL Observation Sentinel Lymph Node Assessment

    Definition of the Observation for the sentinel lymph node assessment

  • CH CRL Observation Serum Tumour Markers

    Definition of the Observation for the serum tumour markers

  • CH CRL Observation Shimada Grading System

    Definition of the Observation for the Shimada grading system

  • CH CRL Observation St. Jude / Murphy Staging

    Definition of the Observation for the St. Jude / Murphy staging

  • CH CRL Observation TNM Stage Group

    Definition of the Observation for the TNM stage group

  • CH CRL Observation Topography of Metastases at Diagnosis

    Definition of the Observation for the topography of metastases at diagnosis

  • CH CRL Observation Topography of Post-diagnosis Metastases

    Definition of the Observation for the topography of post-diagnosis metastases

  • CH CRL Observation Toronto Tier II (Manual) Staging

    Definition of the Observation for the Toronto Tier II (manual) staging

  • CH CRL Observation Tumour Proliferation Labeling

    Definition of the Observation for the tumour proliferation labeling

  • CH CRL Observation Type of Recurrence/Transformation

    Definition of the Observation for the type of recurrence/transformation

  • CH CRL Observation Venous Invasion

    Definition of the Observation for the venous invasion

  • CH CRL Observation WHO Grade Group

    Definition of the Observation for the WHO grade group

  • CH CRL Observation WHO(CNS) Grading System

    Definition of the Observation for the WHO(CNS) grading system

  • CH CRL Observation a-Prefix of pTNM

    Definition of the Observation for the a-Prefix of pTNM

  • CH CRL Observation cM

    Definition of the Observation for the TNM clinical distant metastases category

  • CH CRL Observation cN

    Definition of the Observation for the TNM clinical regional nodes category

  • CH CRL Observation cT

    Definition of the Observation for the TNM clinical primary tumor category

  • CH CRL Observation m-Suffix of pT

    Definition of the Observation for the m-Suffix of pT

  • CH CRL Observation pM

    Definition of the Observation for the TNM pathologic distant metastases category

  • CH CRL Observation pN

    Definition of the Observation for the TNM pathologic regional nodes category

  • CH CRL Observation pT

    Definition of the Observation for the TNM pathologic primary tumor category

  • CH CRL Observation y-Prefix of cTNM

    Definition of the Observation for the y-Prefix of cTNM

  • CH CRL Observation y-Prefix of pTNM

    Definition of the Observation for the y-Prefix of pTNM

  • CH CRL Observation α-fetoprotein

    Definition of the Observation for the α-fetoprotein

  • CH CRL Observation β-hCG

    Definition of the Observation for the β-hCG

  • CH CRL Organization

    Definition of the Organization of which the organization department forms a part

  • CH CRL Organization Department

    Definition of the Organization department (hospital) for reporting to the cancer registry

  • CH CRL Patient

    Definition of the Patient for reporting to the cancer registry

  • CH CRL Practitioner

    Definition of the Practitioner (resident physician) for reporting to the cancer registry

  • CH CRL Procedure Diagnostic Method

    Definition of the Procedure for the diagnostic method(s)

  • CH CRL Procedure Method of First Detection

    Definition of the Procedure for the method of first detection

  • CH CRL Procedure Treatment

    Definition of the Procedure for the treatment